Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.04.02

Sai Life Sciences becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences, today announced its induction into the Pharmaceutical Supply Chain Initiative (PSCI) membership as an ‘Associate Member’.

Welcoming Sai Life Sciences into its fold, a PSCI spokesperson said, “PSCI and its members are delighted to welcome Sai Life Sciences into membership, PSCI’s first member with its main headquarters in India. We are pleased at their enthusiasm in embedding PSCI’s Principles for Responsible Supply Chain Management into their practices, and see their addition to our membership as another heartening sign that responsible practices are gaining influence in a country that’s important to many of our members’ supply chains.”

The PSCI is a non-profit business membership organization with a vision to establish and promote responsible practices that continuously improve pharmaceutical supply chains. All PSCI members are expected to support and incorporate the organization’s core principles that encompass five areas of responsible business practices namely, ethics, labor, health and safety, environment, and management systems, into their supply agreements.

Responding to the announcement, Krishna Kanumuri, CEO & Managing Director said, “We at Sai Life Sciences are truly honoured to be inducted into the PSCI membership and join its esteemed league of companies. This step is a strong reaffirmation of our commitment to implement and champion responsible supply chain practices.”

Sai Life Sciences has firmly adopted Sustainability as an integral part of its business and decision-making framework, shifting from a “compliance-oriented” approach to a more proactive one. It has undertaken several initiatives including setting up an online learning management system, adopting green chemistry principles in process development, building all new facilities as ‘Green Buildings’, sourcing renewable energy, improving employee health & safety through industrial hygiene programs and conducting community development programs on education and health care. The company’s Sustainable Development Goals (SDGs) focus on minimizing its environmental footprint, strengthening diversity & inclusion, giving back to society and improving its supply chain.

Sai Life Sciences has been ISO certified (14001:2015 & 45001:2018) for its R&D and Manufacturing facilities, awarded Silver Medal in the EcoVadis CSR assessment, and rated ‘5-Star’ for Excellence in EHS Practices at the CII-Southern Region awards 2019.

Share article

More News

2025.10.08

Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators

Manchester/Hyderabad, October 08, 2025: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC Partnership designed to provide innovator biopharma companies with end-to-end Chemistry, Manufacturing and Controls (CMC) services. The collaboration combines the extensive CMC expertise of Sai Life Sciences in API […]
Read more

2025.10.06

Unlocking Chemical Frontiers: IIT Bombay Prof, Debabrata Maiti at Sai Life Sciences

As part of Sai Life Sciences’ efforts to foster knowledge exchange and bring leading voices from niche areas of science and technology to its teams, the company recently hosted Prof. Debabrata Maiti from the Indian Institute of Technology (IIT) Bombay at its R&D campus in Hyderabad for a day of scientific exchange and dialogue. The […]
Read more

2025.09.18

Sai Life Sciences opens dedicated facility for Veterinary APIs in Bidar, India

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for veterinary API production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. The new […]
Read more

2025.09.05

Reviving Kudikunta Lake: Bringing nature and community closer together

As part of its Corporate Social Responsibility initiative, Sai Life Sciences has taken up the development of Kudikunta Lake in Hyderabad, reinforcing its commitment to sustainability and community well-being. The Kudikunta Lake initiative marks a significant step in restoring one of Hyderabad’s key lakes and advancing the cause of sustainable urban living. The company has […]
Read more

2025.09.05

From injections to pills: oral peptides set to transform drug development

In a recent article published in Drug Target Review, Dr Santosh Kulkarni highlights the shift from injections to pills. He writes about how oral peptide therapeutics are overcoming the long-standing challenge of poor bioavailability—bringing us closer to patient-friendly medicines without compromising efficacy. The article highlights the booming peptide drug market and the scientific advances—from chemical […]
Read more